1.47
price down icon3.29%   -0.05
after-market Handel nachbörslich: 1.47
loading

Alx Oncology Holdings Inc Aktie (ALXO) Neueste Nachrichten

pulisher
Dec 08, 2025

Alx Oncology rallies on strong phase 2 data for lymphoma therapy - MSN

Dec 08, 2025
pulisher
Dec 08, 2025

Alx Oncology stock soars after impressive lymphoma treatment results By Investing.com - Investing.com UK

Dec 08, 2025
pulisher
Dec 08, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Dec 08, 2025
pulisher
Dec 08, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

ALX Oncology (Nasdaq:ALXO) Reports High Response Rates for Evorpacept Combo in Indolent B-cell NHL at ASH 2025 - Kalkine Media

Dec 08, 2025
pulisher
Dec 07, 2025

ALXO: Promising Phase 2 Trial Results for Evorpacept in iNHL Tre - GuruFocus

Dec 07, 2025
pulisher
Dec 07, 2025

Alx Oncology Holdings Inc. Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-Of-Care Treatment in Patients with Indolent B-Cell Non-Hodgkin Lymphoma, At Ashodgkinlymph - marketscreener.com

Dec 07, 2025
pulisher
Dec 06, 2025

ALX Oncology (NASDAQ:ALXO) Upgraded by Wall Street Zen to Hold Rating - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

ALX Oncology (NASDAQ:ALXO) Stock Price Up 3.8%Here's Why - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Reviewing Harmony Biosciences (NASDAQ:HRMY) and ALX Oncology (NASDAQ:ALXO) - Defense World

Dec 05, 2025
pulisher
Dec 03, 2025

Why ALX Oncology Holdings Inc. stock could benefit from AI revolutionMarket Growth Summary & High Accuracy Trade Signal Alerts - Newser

Dec 03, 2025
pulisher
Nov 27, 2025

HER2-positive Gastric Cancer Clinical Trial Pipeline: Insights into a Growing Landscape with 20+ Companies Advancing Novel Treatments| DelveInsight - GlobeNewswire

Nov 27, 2025
pulisher
Nov 21, 2025

How resilient is ALX Oncology Holdings Inc. stock in market downturnsMarket Trend Summary & Consistent Profit Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Jefferies reiterates Buy rating on ALX Oncology stock, sees potential in cancer programs - Investing.com Canada

Nov 20, 2025
pulisher
Nov 20, 2025

Can ALX Oncology Holdings Inc. hit a new high this month2025 Volatility Report & Daily Profit Maximizing Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

What analyst consensus says on ALX Oncology Holdings Inc. stockQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will ALX Oncology Holdings Inc. stock outperform Dow Jones index2025 Fundamental Recap & Accurate Entry/Exit Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is ALX Oncology Holdings Inc. stock attractive for long term wealth buildingVolume Spike & Expert Curated Trade Setups - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is ALX Oncology Holdings Inc. stock attractive for hedge fundsEntry Point & Consistent Growth Equity Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B - Markets Financial Content

Nov 19, 2025
pulisher
Nov 19, 2025

ALXO: Two high-value oncology programs advance toward key 2025 data with strong financial support - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 06:30:37 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 06:25:55 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail

Nov 19, 2025
pulisher
Nov 19, 2025

Will ALX Oncology Holdings Inc. stock deliver long term returnsCEO Change & Entry Point Confirmation Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-18 23:37:11 - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Analyzing ALX Oncology Holdings Inc. with risk reward ratio charts2025 Trading Recap & Daily Growth Stock Tips - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Published on: 2025-11-18 12:31:34 - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

ALX Oncology to Present at Upcoming Investor Conferences - The Manila Times

Nov 18, 2025
pulisher
Nov 18, 2025

1stdibs.Com And 2 Other Penny Stocks To Watch Closely - simplywall.st

Nov 18, 2025
pulisher
Nov 18, 2025

Published on: 2025-11-18 00:39:17 - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Statistical indicators supporting ALX Oncology Holdings Inc.’s strengthQuarterly Growth Report & Consistent Profit Trading Strategies - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Will ALX Oncology Holdings Inc. outperform the marketJuly 2025 Catalysts & Community Verified Swing Trade Signals - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

ALX Oncology Holdings (ALXO) Price Target Increased by 12.50% to 3.06 - Nasdaq

Nov 16, 2025
pulisher
Nov 16, 2025

Applying Wyckoff theory to ALX Oncology Holdings Inc. stock2025 Institutional Moves & Safe Swing Trade Setup Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Will ALX Oncology Holdings Inc. continue its uptrendPortfolio Risk Summary & Low Drawdown Momentum Trade Ideas - newser.com

Nov 16, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):